Andersen O
Environ Health Perspect. 1984 Mar;54:249-66. doi: 10.1289/ehp.8454249.
The toxicity of cadmium is determined by chelation reactions: in vivo, Cd2+ exists exclusively in coordination complexes with biological ligands, or with administered chelating agents. The Cd2+ ion has some soft character, but it is not a typical soft ion. It has a high degree of polarizability, and its complexes with soft ligands have predominantly covalent bond characteristics. Cd2+ forms the most stable complexes with soft donor atoms (S much greater than N greater than 0). The coordination stereochemistry of Cd2+ is unusually varied, including coordination numbers from 2 to 8. Even though the Cd2+ ion is a d10 ion, disturbed coordination geometries are often seen. Generally, the stability of complexes increases with the number of coordination groups contributed by the ligand; consequently, complexes of Cd2+ with polydentate ligands containing SH groups are very stable. Cd2+ in metallothionein (MT) is coordinated with 4 thiolate groups, and the log stability constant is estimated to 25.5. Complexes between Cd2+ and low molecular weight monodentate or bidentate ligands, e.g., free amino acids (LMW-Cd), seem to exist very briefly, and Cd2+ is rapidly bound to high molecular weight proteins, mainly serum albumin. These complexes (HMW-Cd) are rapidly scavenged from blood, mainly by the liver, and Cd2+ is redistributed to MT. After about 1 day the Cd-MT complex (MT-Cd) almost exclusively accounts for the total retained dose of Cd2+, independent of the route of exposure. MT-Cd is slowly transferred to and accumulated in kidney cortex. The acute toxicity and interorgan distribution of parenterally administered Cd2+ are strongly influenced by preceding MT induction, or decreased capacity for MT synthesis; however, the gastrointestinal (GI) uptake of Cd2+ seems unaffected by preceding MT induction resulting in considerable capacity for Cd2+ chelation in intestinal mucosa, and this finding indicates that endogenous MT is not involved in Cd2+ absorption. The toxicity of parenterally administered Cd2+ is strongly enhanced when administered as complexes with NTA or STPP , but it is much decreased when administered as a complex with EDTA. In chronic oral exposure the toxicity and GI uptake of Cd2+ is not changed when Cd2+ is administered as a complex with the detergent formula chelating agents NTA, EDTA and STPP . The uptake of Cd2+ from ligated intestine in vivo was not affected by administration of Cd2+ as complexes with CYS or GSH, but significantly reduced by complexation with EDTA or BAL. The acute toxicity of orally administered Cd2+ is reduced when Cd2+ is administered as a complex with EDTA.(ABSTRACT TRUNCATED AT 400 WORDS)
在体内,Cd2+仅以与生物配体或施用的螯合剂形成的配位络合物形式存在。Cd2+离子具有一定的软特性,但它不是典型的软离子。它具有高度的极化率,其与软配体形成的络合物主要具有共价键特征。Cd2+与软供体原子(S远大于N大于O)形成最稳定的络合物。Cd2+的配位立体化学异常多样,包括配位数从2到8。尽管Cd2+离子是d10离子,但经常可见配位几何结构受到干扰。一般来说,络合物的稳定性随着配体贡献的配位基团数量增加而增加;因此,Cd2+与含SH基团的多齿配体形成的络合物非常稳定。金属硫蛋白(MT)中的Cd2+与4个硫醇盐基团配位,其对数稳定常数估计为25.5。Cd2+与低分子量单齿或双齿配体(如游离氨基酸,LMW-Cd)之间的络合物似乎存在时间很短,Cd2+会迅速与高分子量蛋白质(主要是血清白蛋白)结合。这些络合物(HMW-Cd)主要由肝脏迅速从血液中清除,Cd2+被重新分布到MT中。大约1天后,Cd-MT络合物(MT-Cd)几乎完全占Cd2+总保留剂量,与暴露途径无关。MT-Cd缓慢转移并积聚在肾皮质中。经肠胃外给药的Cd2+的急性毒性和器官间分布受到先前MT诱导或MT合成能力降低的强烈影响;然而,Cd2+的胃肠道(GI)吸收似乎不受先前MT诱导的影响,导致肠黏膜中有相当大的Cd2+螯合能力,这一发现表明内源性MT不参与Cd2+的吸收。当与NTA或STPP形成络合物给药时,经肠胃外给药的Cd2+的毒性会大大增强,但与EDTA形成络合物给药时毒性会大大降低。在慢性口服暴露中,当Cd2+与洗涤剂配方螯合剂NTA、EDTA和STPP形成络合物给药时,Cd2+的毒性和GI吸收没有变化。体内从结扎肠中吸收Cd2+不受与CYS或GSH形成络合物给药的影响,但与EDTA或BAL络合会显著降低吸收。当Cd2+与EDTA形成络合物给药时,口服Cd2+的急性毒性会降低。(摘要截于400字)